Lab Updates
Announcements and updates from the Maher Laboratory.
May 1, 2025
A new paper from the Maher Lab published in BMC Biology reports transcriptomic evidence of oxytosis/ferroptosis activation in human Alzheimer's disease brain samples, supporting a central role for this pathway in disease.
May 1, 2025
A study from the Maher Lab published in Redox Biology demonstrates that cannabinol (CBN) significantly improves spatial learning and memory in the SAMP8 aging mouse model, with effects linked to mitochondrial and synaptic improvements.
September 1, 2024
CMS121, a drug candidate developed in the Maher Laboratory as a derivative of the flavonol fisetin, continues to advance through human clinical trials for the treatment of Alzheimer's disease.